Canada issues warning about Viagra vision loss
Tue Jul 26, 2005 5:53 PM BST

OTTAWA (Reuters) - Canada advised users of the erectile dysfunction drugs Viagra, Cialis and Levitra on Tuesday to "seek immediate medical attention" if they experience sudden vision loss or other vision-related problems when taking the medications.

Canada's health ministry said it was likely to change the product information for the three drugs. Earlier this month the U.S. Food and Drug Administration approved new labeling to warn men about possible blindness from Pfizer Inc.'s Viagra.

The U.S. warning labels also affect Cialis -- sold by Eli Lily & Co. and Icos Corp. -- and Levitra, which is co-promoted by GlaxoSmithKline and Bayer AG .

Quote from Torre:

Canada issues warning about Viagra vision loss
Tue Jul 26, 2005 5:53 PM BST

OTTAWA (Reuters) - Canada advised users of the erectile dysfunction drugs Viagra, Cialis and Levitra on Tuesday to "seek immediate medical attention" if they experience sudden vision loss or other vision-related problems when taking the medications.

Canada's health ministry said it was likely to change the product information for the three drugs. Earlier this month the U.S. Food and Drug Administration approved new labeling to warn men about possible blindness from Pfizer Inc.'s Viagra.

The U.S. warning labels also affect Cialis -- sold by Eli Lily & Co. and Icos Corp. -- and Levitra, which is co-promoted by GlaxoSmithKline and Bayer AG .

Hi Torre

Thank you for passing on the information. Once I heard a doctor say (on PBS) that one should not take any new drug until it has been on the market for at least five years. I remember before trying the Cialis I researched the history of Viagra and found it had actually been approved by the FDA in 1998? My cardiologist didn’t even give it a second thought when he suggested I try the IP drugs. One would have thought that this problem would have showed up many years ago! Torre you seem to really be on top of these eye/drug issues. Do you work in the Ophthalmology field?